LEADER 04014nam 2201081z- 450 001 9910557128803321 005 20210501 035 $a(CKB)5400000000040766 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68424 035 $a(oapen)doab68424 035 $a(EXLCZ)995400000000040766 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aClinical Research on Diabetic Complications 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (204 p.) 311 08$a3-03943-825-5 311 08$a3-03943-826-3 330 $aRefrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change. 606 $aHistory of engineering and technology$2bicssc 610 $aAlzheimer's disease 610 $aarterial stiffness 610 $aaspirin 610 $abaPWV 610 $abariatric surgery 610 $abranched-chain amino acids 610 $aburnt-out diabetes 610 $acardiovascular disease 610 $acarotid plaque 610 $acerebrovascular disease 610 $achronic kidney disease (CKD) 610 $adementia 610 $adermal electrochemical conductance 610 $adiabetes 610 $adiabetes mellitus 610 $adiabetic foot disease 610 $adiabetic foot syndrome 610 $adiabetic kidney disease 610 $adiabetic macroangiopathy 610 $adiabetic microangiopathy 610 $adiabetic neuropathy 610 $adiabetic retinopathy 610 $adialysis 610 $adipeptidyl peptidase 4 inhibitors 610 $adipeptidyl-peptidase IV inhibitors 610 $aechogenic plaque 610 $aend-stage renal disease (ESRD) 610 $afibroblast growth factor 23 610 $aglucagon-like peptide-1 receptor agonists 610 $aglucose fluctuations 610 $aheart disease 610 $aincident diabetes mellitus (DM) 610 $ainflammation 610 $ainsulin resistance 610 $aKlotho 610 $ameta-analysis 610 $ametabolomics 610 $amicroperimetry 610 $aneuropathy 610 $aNMR spectroscopy 610 $aobesity 610 $apatient-reported outcomes 610 $aperipheral artery disease 610 $aplaque characteristics 610 $aprediabetes 610 $aprimary care 610 $aprimary prevention 610 $aquality of life 610 $areno-cardiovascular protection 610 $asarcopenia 610 $asCD36 610 $ascreening 610 $asodium-glucose co-transporter 2 inhibitors 610 $asudomotor reflex 610 $atreatment satisfaction 610 $atrial sequential analysis 610 $atype 1 diabetes 610 $atype 1 diabetes mellitus 610 $atype 2 610 $atype 2 diabetes mellitus 610 $avascular 610 $avascular disease 615 7$aHistory of engineering and technology 700 $aMauricio$b Didac$4edt$01302198 702 $aMauricio$b Didac$4oth 906 $aBOOK 912 $a9910557128803321 996 $aClinical Research on Diabetic Complications$93026239 997 $aUNINA